Copyright Reports & Markets. All rights reserved.

Global DNA Vaccination Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global DNA Vaccination Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Human DNA Vaccines
      • 1.4.3 Animal DNA Vaccines
    • 1.5 Market by Application
      • 1.5.1 Global DNA Vaccination Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Research and Academic Laboratories
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 DNA Vaccination Market Size
    • 2.2 DNA Vaccination Growth Trends by Regions
      • 2.2.1 DNA Vaccination Market Size by Regions (2014-2025)
      • 2.2.2 DNA Vaccination Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 DNA Vaccination Market Size by Manufacturers
      • 3.1.1 Global DNA Vaccination Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global DNA Vaccination Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global DNA Vaccination Market Concentration Ratio (CR5 and HHI)
    • 3.2 DNA Vaccination Key Players Head office and Area Served
    • 3.3 Key Players DNA Vaccination Product/Solution/Service
    • 3.4 Date of Enter into DNA Vaccination Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global DNA Vaccination Market Size by Type (2014-2019)
    • 4.2 Global DNA Vaccination Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States DNA Vaccination Market Size (2014-2019)
    • 5.2 DNA Vaccination Key Players in United States
    • 5.3 United States DNA Vaccination Market Size by Type
    • 5.4 United States DNA Vaccination Market Size by Application

    6 Europe

    • 6.1 Europe DNA Vaccination Market Size (2014-2019)
    • 6.2 DNA Vaccination Key Players in Europe
    • 6.3 Europe DNA Vaccination Market Size by Type
    • 6.4 Europe DNA Vaccination Market Size by Application

    7 China

    • 7.1 China DNA Vaccination Market Size (2014-2019)
    • 7.2 DNA Vaccination Key Players in China
    • 7.3 China DNA Vaccination Market Size by Type
    • 7.4 China DNA Vaccination Market Size by Application

    8 Japan

    • 8.1 Japan DNA Vaccination Market Size (2014-2019)
    • 8.2 DNA Vaccination Key Players in Japan
    • 8.3 Japan DNA Vaccination Market Size by Type
    • 8.4 Japan DNA Vaccination Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia DNA Vaccination Market Size (2014-2019)
    • 9.2 DNA Vaccination Key Players in Southeast Asia
    • 9.3 Southeast Asia DNA Vaccination Market Size by Type
    • 9.4 Southeast Asia DNA Vaccination Market Size by Application

    10 India

    • 10.1 India DNA Vaccination Market Size (2014-2019)
    • 10.2 DNA Vaccination Key Players in India
    • 10.3 India DNA Vaccination Market Size by Type
    • 10.4 India DNA Vaccination Market Size by Application

    11 Central & South America

    • 11.1 Central & South America DNA Vaccination Market Size (2014-2019)
    • 11.2 DNA Vaccination Key Players in Central & South America
    • 11.3 Central & South America DNA Vaccination Market Size by Type
    • 11.4 Central & South America DNA Vaccination Market Size by Application

    12 International Players Profiles

    • 12.1 Inovio Pharmaceuticals
      • 12.1.1 Inovio Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 DNA Vaccination Introduction
      • 12.1.4 Inovio Pharmaceuticals Revenue in DNA Vaccination Business (2014-2019)
      • 12.1.5 Inovio Pharmaceuticals Recent Development
    • 12.2 Merck
      • 12.2.1 Merck Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 DNA Vaccination Introduction
      • 12.2.4 Merck Revenue in DNA Vaccination Business (2014-2019)
      • 12.2.5 Merck Recent Development
    • 12.3 Astellas Pharma
      • 12.3.1 Astellas Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 DNA Vaccination Introduction
      • 12.3.4 Astellas Pharma Revenue in DNA Vaccination Business (2014-2019)
      • 12.3.5 Astellas Pharma Recent Development
    • 12.4 Pfizer
      • 12.4.1 Pfizer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 DNA Vaccination Introduction
      • 12.4.4 Pfizer Revenue in DNA Vaccination Business (2014-2019)
      • 12.4.5 Pfizer Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      DNA vaccination is a technique for protecting against disease by injection with genetically engineered DNA so cells directly produce an antigen, producing a protective immunological response.
      In 2018, the global DNA Vaccination market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global DNA Vaccination status, future forecast, growth opportunity, key market and key players. The study objectives are to present the DNA Vaccination development in United States, Europe and China.

      The key players covered in this study
      Inovio Pharmaceuticals
      Merck
      Astellas Pharma
      Pfizer
      ...

      Market segment by Type, the product can be split into
      Human DNA Vaccines
      Animal DNA Vaccines

      Market segment by Application, split into
      Hospitals
      Research and Academic Laboratories
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global DNA Vaccination status, future forecast, growth opportunity, key market and key players.
      To present the DNA Vaccination development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of DNA Vaccination are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now